abstract: Cryobanking and transplantation of ovarian tissue is a promising approach to restore fertility in cancer patients. However, ischemic stress following avascular ovarian cortex grafting is known to induce stromal tissue fibrosis and alterations in follicular development. The aim of the study was to analyze the impact of freeze-thawing and grafting procedures on gene expression in human ovarian tissue. Frozen-thawed ovarian tissue from 14 patients was xenografted for 7 days to nude mice and one ungrafted fragment was used as a control. Immediately after recovery, grafts were processed for RNA extraction and histological analysis. Their expression profile was screened by whole-genome oligonucleotide array (n ¼ 4) and validated by reverse-transcriptase polymerase chain analysis (n ¼ 10). After data filtering, the Limma package was used to build a linear regression model for each gene and to compute its fold change between tissues on Days 0 and 7. After adjusting the P-value by the Sidak method, 84 of the transcripts were significantly altered after 7 days of grafting, including matrix metalloproteinase-9 and -14 and angiogenic factors such as placental growth factor and C-X-C chemokine receptor type 4 (CXCR4). Major biological processes were related to tissue remodeling, including secretory processes, cellular adhesion and response to chemical and hormonal stimuli. Angiopoietin signaling, the interleukin-8 pathway and peroxisome proliferator-activated receptor activation were shown to be differentially regulated. On Day 7, overexpression was confirmed by PCR for interleukin-8, transforming growth factor-beta 1, matrix metalloproteinase-14 and CXCR4, compared with ungrafted controls. In conclusion, new as well as known genes involved in tissue restructuring and angiogenesis were identified and found to play a key role during the first days after human ovarian tissue transplantation. This will facilitate the development of strategies to optimize grafting techniques.
Introduction
Recent progress in cancer therapies has significantly increased longterm survival rates in patients. Unfortunately, these treatments can be very harmful to the ovaries, resulting in loss of both endocrine and reproductive functions in women (Wallace et al., 2005; Donnez et al., 2006) . Cryopreservation and transplantation of ovarian tissue is now offered in an increasing number of reproductive medicine centers to preserve fertility of cancer patients in cases where embryo or oocyte cryopreservation cannot be applied. Since the birth of the first baby after orthotopic transplantation of frozenthawed ovarian tissue (Donnez et al., 2004) , 24 live births have been reported .
However, some limitations of the procedure have been described. Grafting of frozen -thawed ovarian tissue in patients has shown limited graft life span, poor responder hormone profiles and empty follicles upon aspiration (Meirow et al., 2007; Donnez et al., 2008; Dolmans et al., 2009) . Experimental studies appear to show a decline in the primordial follicular pool (Baird et al., 1999; Nisolle et al., 2000) , follicular activation (Dolmans et al., 2007) and asynchronized development of oocyte and follicular cells . Further investigations are therefore required to improve the technique.
Ischemic stress is thought to be one of the factors limiting the success of the procedure (Israely et al., 2004; Wu et al., 2010; Friedman et al., 2012) . Ovarian cortical pieces are grafted without vascular anastomosis and implants are thus exposed to ischemic damage during an initial posttransplantation period until they become revascularized (Van Eyck et al., 2009 . During this period, profound modifications of gene regulation and physiological functions are critical for tissue survival in anaerobic conditions. However, these modifications could induce alterations in stromal tissue and deregulation of ovarian function, resulting in follicle loss and disordered follicular activation (David et al., 2012) . It is therefore important to understand which processes are triggered by transplantation and ischemic stress in ovarian grafts.
Multiple signaling pathways are activated in mammalian cells during ischemia/reperfusion injury in an attempt to minimize cellular injury and maintain tissue function. Among the transcriptional regulators activated are members of the hypoxia inducible factor (HIF) transcription factor family. HIF factors regulate a variety of genes that affect a myriad of cellular processes, including metabolism, angiogenesis, cell survival and proliferation, all of which are important to maintain cell viability (Ke and Costa, 2006) .
All available data on transcriptional regulation in case of ischemic stress in ovarian tissue have been obtained from murine models. After autotransplantation of immature rat ovary, a huge increase in the expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta 1 (TGFb1) was evidenced during vascular ingrowths by RNA blot hybridization (Dissen et al., 1994) . Similarly, Yang et al. (2008) showed an increase in VEGF expression in grafted immature rat ovaries 2 days after transplantation by RT-PCR and western blot. Agca et al. (2009) recently reported alterations in the expression of genes involved in metabolism and growth, as well as those involved in the inflammatory response after xenotransplantation of rat ovaries into mice for 12 weeks. One study performed on human fetal ovarian tissue demonstrated a sharp increase in VEGF and angiopoietin-2 expression 2 days after xenotransplantation to nude mice (Wu et al., 2010) .
Xenografting of human ovarian tissue to mice has proved to be an effective model to study ovarian function and follicle development in vivo (Van Eyck et al., 2009a, b) . This model is also applied to assess gonadotoxicity of treatment, evaluate the risk of reimplanting malignant cells and optimize cryopreservation and grafting protocols.
In order to better understand the factors responsible for altered development of normal-looking follicles, it is important to gather information on the transcriptional profile of frozen-thawed ovarian tissue xenografts.
Here we analyzed the impact of freeze-thawing and grafting procedures on gene expression of human ovarian tissue after 2 and 7 days of grafting to nude mice. These time points were chosen based on recent identification by electron paramagnetic resonance (EPR) of the hypoxic period before Day 5 and progressive reoxygenation thereafter (Van Eyck, 2009 ). Oligonucleotide microarray (Affymetrix) was applied as a tool to screen expression of thousands of genes at a time. This approach allows identification of differential expression of genes not previously described or expected to be involved in a particular process.
Materials and Methods

Experimental design
In this study, ovarian tissue was obtained from 14 patients. Each biopsy was divided into seven fragments. One fragment served as a fresh control in order to evaluate the presence of follicles. The other six fragments were slowfrozen.
Immediately after thawing (Day 0), one fragment was fixed in formol for histological examination and another was placed in TRIzol reagent (Invitrogen) for RNA extraction to control RNA quality after cryopreservation. After extraction, RNA quality was assessed using the Agilent 2100 Bioanalyzer. The four remaining fragments were grafted to the intraperitoneal cavity of two nude mice. A total of 28 mice were grafted, each mouse receiving two fragments from the same patient. The mice were euthanized on Day 2 or 7 post-transplantation.
After graft retrieval, total RNA was extracted and its quality assessed. Among the 14 pairs of mice, 4 were used for microarray analysis and RT-qPCR evaluation. The other 10 pairs of mice served for additional RT-qPCR validation of the microarray analyses. Microarray analysis was performed on ungrafted fragments and Day 7 grafts, while PCR analyses were carried out on ungrafted tissue, and Day 2 and 7 grafts.
Tissue collection and freezing
Use of human tissue for this study was approved by the Institutional Review Board of the Université Catholique de Louvain. After obtaining written informed consent, ovarian biopsies measuring 8 × 4 mm were obtained from 14 women (between 22 and 38 years of age, 26.9 + 6.9 years) undergoing laparoscopic surgery for benign gynecologic disease. After retrieval, ovarian tissue was immersed in a solution of N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)-buffered modified Eagle's medium (HEPES-MEM) (MEM, Invitrogen, Carlsbad, CA, USA) and immediately transferred from the operating room to the research laboratory on ice. The medullar part was removed and each ovarian biopsy specimen was dissected into seven cortical strips of 2 × 4 mm. Freezing of the ovarian tissue strips was performed according to the method applied for ovarian tissue banking . The tissue was first suspended in 800 ml of minimal essential medium (MEM)-Glutamax TM (Invitrogen) in a cryovial. This medium was then replaced with the same amount of a cryoprotective solution containing 10% dimethyl sulfoxide (Sigma, St Louis, MO, USA) and 2% human serum albumin (Sanquin, Amsterdam, the Netherlands) in Leibowitz-15 medium (Invitrogen) at 48C. The cryovials were cooled in a programmable freezer using the following program: (i) cooled from 08C to 288C at 228C/min; (ii) seeded manually by touching the cryovials with forceps pre-chilled in liquid nitrogen; (iii) cooled to 2408C at 20.38C/min and transferred to liquid nitrogen for storage.
For thawing and cryoprotectant removal, the cryovials were exposed to room temperature for 2 min and immersed in a water bath at 378C until the ice completely melted. To remove the cryoprotective solution, the ovarian tissue was transferred from the cryovials to Petri dishes containing MEM-Glutamax, where it was washed three times (5 min per bath).
Transplantation into nude mice
Guidelines for animal welfare were approved by the Committee on Animal Research of the Université Catholique de Louvain. The 7-to 10-week-old female mice (NMRI nu/nu, Janvier, Le Genest St Isle, France) were housed in groups of five per cage, maintained at 288C under controlled sterile conditions, with a 12-h light/dark cycle and free access to an autoclaved pelleted diet and water.
The mice were anesthetized by injection of ketamine (75 mg/kg; Eurovet, Heusden-Zolder, Belgium) and medetomidine (1 mg/kg Domitor; Pfizer, Cambridge, MA, USA). Cortical fragments were grafted intraperitoneally as previously described by Van Eyck et al. (2009) . A horizontal incision was made and ovarian fragments were fixed to the lower third of the parietal peritoneum with Prolene 7/0. Each mouse received two ovarian fragments. The abdominal wall and skin were then closed with 6/0 Prolene.
Anesthesia was reversed by injection of atipamezole (1 mg/kg Antisedan; Pfizer). After 2 or 7 days, the animals were euthanized by cervical dislocation and the grafts were recovered. For each mouse, one graft was fixed in formol for histological and immunohistochemical analyses and the second was transferred to TRIzol Reagent for RNA extraction.
Histological analysis
The presence of follicles was checked in fresh tissue (Day 0, n ¼ 14) and after cryopreservation and grafting (Days 2 and 7, n ¼ 28). For this purpose, the ovarian fragments were dehydrated, embedded in paraffin and serially sectioned (5-mm-thick sections). Every sixth slide was stained with hematoxylin -eosin (Merck, Darmstadt, Germany) for histological evaluation; the other slides (Superfrost Plus slides; Menzel-Glaser) were kept for immunostaining.
RNA extraction and quality assessment RNA was extracted from Day 0 fresh tissue and from Day 2 and 7 grafts.
Total RNA extraction was carried out at 48C using TRIzol Reagent according to the protocol of Chomczynski and Sacchi (2006) . Briefly, each piece of ovarian tissue was homogenized using an Ultra-Turrax T25 homogenizer (Janke and Kunkel, Brussels, Belgium) with 1 ml of TRIzol Reagent (Invitrogen). After sample lysis, 0.2 ml of chloroform (Merck) was added and the mixture was separated into three phases by centrifugation. RNA in the clear aqueous layer was carefully collected and precipitated by adding 0.5 ml of isopropanol (Merck). The RNA pellet was washed with 75% ethanol (Merck) and then redissolved in nuclease-free water. RNA samples were further purified using RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's RNA clean-up protocol. RNA samples were stored at 2808C until use.
RNA concentrations were determined using a micro-volume spectrophotometer (NanoDrop ND1000, Thermoscientific). An Agilent 2100 Bioanalyzer automated analysis system (Agilent Technologies, Palo Alto, CA) was used to assess the quality (RNA integrity number) of each RNA sample. Only groups in which all three samples (Days 0, 2 and 7) had an RNA integrity number (RIN) ≥6.5 were included in the analysis (n ¼ 10).
The RNA was divided into two for subsequent applications: microarray and PCR.
Oligonucleotide microarray
Differential gene expression in frozen -thawed human ovarian tissue was assessed before (Day 0) and after (Day 7) grafting. All experiments were performed using GeneChip Human Genome U133A 2.0 oligonucleotide arrays, which contain 22 277 probe sets representing 20 374 transcripts and variants, including 12 701 well-characterized human genes. Day 2 samples were also processed for microarray analysis, but they did not meet the Affymetrix quality control criteria.
The eight (4 Day 0 and 4 Day 7) RNA samples destined for GeneChip hybridization were processed using the RNA amplification protocol described by Affymetrix (Affymetrix Expression Manual). Briefly, purified total RNA is reverse transcribed to synthesize first-strand complementary DNA (cDNA). Thereafter, this cDNA is converted into a double-stranded cDNA template for transcription. In vitro transcription is then performed to produce biotinlabeled complementary RNA using Affymetrix GeneChip 3 ′ Amplification One-Cycle Target Labeling and Control Reagents (Affymetrix, High Wycombe). Fifteen micrograms of biotinylated RNA was thus hybridized for 16 h to Affymetrix GeneChip Human Genome U133A 2.0. Immediately following hybridization, the probe array undergoes an automated washing and staining protocol using the Fluidics Station 450 (Affymetrix), as described in the Affymetrix GeneChip Expression Analysis Technical Manual. Scanning was performed using the Affymetrix GeneChip Scanner 3000.
Microarray data analysis
Microarray data were analyzed using Bioconductor R packages. First, raw data CEL files were imported and the quality of each microarray was checked. Then, raw data were preprocessed using the RMA method and a first expression matrix was obtained. A filtering step was applied in order to remove genes with a very low expression level across all tissues [more than 75% of intensities lower than Log2(50)] or with very low expression level variation (interquartile of intensities lower than 0.3). The Limma package was used to build a linear regression model for each gene and compute its fold change between Day 0 and 7 tissues and its P-value. Tight control of the family-wise Type I error rate was performed using the Sidak step-down adjustment of P-values. All microarray data complied with MIAME standards and were submitted to the Gene Expression Omnibus.
Gene set enrichment analysis
Gene set enrichment analysis was performed to identify the list of gene ontologies and KEGG pathways modified between Days 0 and 7. This analysis was applied to the list of each gene with an adjusted P-value lower than 0.05 and with a fold change higher than 2.
Network enrichment analysis
To analyze microarray expression data in more depth, the Ingenuity Pathway Analysis (Ingenuity Systems) tool was used.
Biological networks of differentially expressed genes were generated using this software. Networks are shown as nodes and lines: nodes represent genes and lines represent the relationships between the genes. All lines are supported by at least one reference from the literature. The intensity of node color indicates the degree of up-(red) or down-(green) regulation. Nodes are displayed using various shapes representing the functional class of the gene product.
Quantitative PCR validation
Based on microarray results and gene and network enrichment analysis, five transcripts with a known biological function in inflammatory, angiogenic and apoptotic processes were chosen and analyzed using RT -PCR (Table I) .
Relative mRNA levels of these selected transcripts after ovarian grafting were determined by RT -PCR in the 10 Day 0, 2 and 7 RNA samples (including samples analyzed by microarray). All samples were selected on the basis of the same quality criteria (presence of follicles in fresh controls and RIN ≥ 6.5).
Total RNA (2.5 mg) was reverse transcribed with random hexamers (Eurogentec, Seraing, Belgium) and SuperScript RT RNase H2 reverse transcriptase (Life Technologies, Gaithersburg, MD, USA).
All real-time PCR experiments were performed using the TaqMan gene expression system (Applied Biosystems, Foster City, CA, USA) with TaqMan probes, as detailed in Table I . Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was selected as an endogenous RNA control. All PCR reactions were performed using an ABI Prism 7700 sequence detection system (Perkin-Elmer, Applied Biosystems). After an initial cDNA denaturation and Taq polymerase activation step for 10 min at 958C, cDNA was amplified for 40 cycles of 1 min at 958C and 1 min at 608C. PCR was performed in duplicate for each sample and negative controls were included.
Gene transcript expression levels were calculated by subtracting the GAPDH CT value from transcript CT values ( (IL-8), CX-cytokine receptor-4 (CXCR4) and TGFb1 gene expression was carried out using the DDCT method (Applied Biosystems User Bulletin Number 2, docs.appliedbiosystems.com/pebiodocs/04303859.pdf). Foldchange differences in the five transcripts were determined as 2 2 (DCT sample 2 DCT control). The non-parametric two-tailed Mann-Whitney U-test was used and a P-value of ,0.05 was considered statistically significant. Statistical analysis was performed using SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA).
Immunohistochemical staining
One section per fresh tissue sample (Day 0, n ¼ 10) and one per graft (Day 7, n ¼ 10) were immunostained with anti-CXCR4 antibodies (UMB2 clone, Abcam, Cambridge, UK) to localize the presence of the protein. Sections showing follicles in the previous serial section were selected for this purpose.
Tissue sections were deparaffinized in Histosafe (YVSOLAB S.A., Beerse, Belgium), hydrated in isopropanol (Merck, Darmstadt, Germany), washed briefly in water and incubated in 3% hydrogen peroxide (Merck) for 30 min to block endogenous peroxidase activity. Slides were rinsed in water and heat epitope retrieval was performed for 20 min at 968C using tris(hydroxymethyl)aminomethane (Tris) buffer 10 mM, pH 9.0 (Merck), supplemented with ethylenediaminetetraacetic acid 1 mM and 0.1% Tween 20 (SigmaAldrich, Steinheim, Germany). Sections were rinsed in Tris-buffered saline (TBS)/Triton X100. Endogenous biotin was blocked using the avidin/biotin blocking kit from Vector (SP2001; Vector Laboratories, CA, USA). Nonspecific reactions were blocked in normal goat serum (NGS) 10% + bovine serum albumin (BSA) 1% (Sigma-Aldrich) in TBS for 30 min at room temperature. Sections were then incubated overnight at 48C with rabbit monoclonal anti-CXCR4 antibody (1/100, clone UMB2, Abcam) in NGS 1% + BSA 0.1% in TBS, rinsed in TBS/Triton X100, and incubated for 1 h at room temperature with anti-rabbit biotinylated secondary antibody (1/100, Dako, CA, USA). The slides were again rinsed in TBS/Triton X100 and incubated with horseradish peroxidase/streptavidin reagent (E0432, Vector). The presence of peroxidase was revealed using 3,3 ′ -diaminobenzidine (Dako) for 10 min at room temperature. They were then rinsed in water and specimens were counterstained with Mayer's hemalum solution (Merck, Darmstadt, Germany). Tissue sections were finally dehydrated in isopropanol and Histosafe, and mounted using DPX (Prosan, Merelbeke, Belgium).
Results
Histological evaluation of ovarian tissue
As shown in Fig. 1A , the histology of frozen-thawed ungrafted ovarian tissue was similar to that of fresh tissue. In all fragments included in the study, numerous follicles were found and stromal tissue did not show any alterations.
After 2 days of grafting, an extensive necrotic area was observed mainly in the center of grafts (Fig. 1B) . Despite the presence of necrosis, follicles were observed in all grafts.
After 7 days of grafting, fibrosis was found to have replaced the necrosis seen in the central part of grafts, and vessels containing red blood cells were observed throughout the fragments (Fig. 1C) . Follicles were observed in all grafts recovered after 7 days.
Microarray analyses
Differential gene expression between ungrafted and intraperitoneally grafted human frozen -thawed ovarian tissue was determined using a human-specific oligonucleotide microarray targeting 20 374 transcripts. A total of 8 microarrays, including 4 ungrafted tissue samples and 4 matched grafted tissue samples, were performed. A filtering step was applied in order to remove genes with very low expression levels across all tissues or with very low expression level variation. It should be noted that most transcripts encoding factors involved in folliculogenesis showed low expression levels and were excluded by the data filtering step. After 7 days of grafting, 84 of the transcripts were highly significantly altered (adjusted P-value , 0.01 and fold change . 2). Among these transcripts, 35 were up-regulated and 49 down-regulated at least two-fold compared with corresponding ungrafted tissue, as detailed in Tables II and III . Strong up-regulation of several members of the MMP family (MMP-9 and MMP-14) was observed. A number of genes involved in angiogenic processes were differentially expressed between grafted and ungrafted tissue, such as placental growth factor, C-X-C chemokine receptor type 4 (CXCR4), endothelial cell-specific molecule 1 and homeobox A5 (involved in vascular remodeling). Some factors involved in neurogenic processes were found to be down-regulated after grafting, including neuron-specific gene family member 1, dystrophin, neurofascin and synaptotagmin I.
Gene ontologies and KEGG pathway analysis
We identified functional categories that were overrepresented after 7 days of grafting compared with controls. As reported in Table IV , major biological processes were related to tissue remodeling, including secretory processes, processes associated with tissue development, cellular adhesion and response to chemical and hormonal stimuli. As shown in Table V , the most affected cellular components were those related to the extracellular matrix and granule secretion. Interestingly, the most Figure 1 Histological appearance of human ovarian tissue before and after grafting for 2 and 7 days into the pelvic cavity of nude mice; (A) ungrafted frozen-thawed tissue with pre-antral follicles at various stages; (B) frozen-thawed tissue from the same patient grafted for 2 days and (C) for 7 days.
Gene expression in xenografted human ovarian tissue significant pathways evidenced by KEGG analysis (Table VI) 
Ingenuity pathway analysis
To analyze gene expression data in greater depth, the Ingenuity Pathway Analysis tool was used.
The following networks were highly enriched in grafted tissue: protein synthesis, embryonic development and tissue development (enrichment score ¼ 26); molecular transport, neurological disease, DNA replication, recombination and repair (enrichment score ¼ 26); embryonic development, organismal development and cell signaling (enrichment score ¼ 24); cell morphology, cellular function and maintenance and connective tissue development and function (enrichment score ¼ 24) consistent with tissue repair and restructuring. The main network affected in grafted tissue is shown in Fig. 2 , pointing to TGFb as a key mediator of the post-grafting inflammatory response.
The top canonical pathway identified included angiopoietin signaling (P ¼ 5.51 × 10 204 , involving 39 genes significantly up-or downregulated out of 74 genes included in the pathway), inhibition of angiogenesis by thrombospondin-1 (P ¼ 1.74 × 10
203
, involving 22 out of 39 genes), the IL-8 pathway (P ¼ 1. 
Quantitative real-time PCR validation
Expression of a subset of five up-regulated genes was validated by realtime PCR quantification on samples included in the microarray analysis (n ¼ 4 Day 0, n ¼ 4 Day 7) and on additional samples (n ¼ 6 day 0, n ¼ 6 day 7). Ten Day 2 samples were also evaluated. The following gene transcripts were selected, as detailed in Table I : interleukin-8, VEGF, TGFb1, MMP14 and CXCR4. Expression of all transcripts was normalized using GAPDH as a reference. As shown in Table VII , analysis of RT -PCR data indicates that IL-8, MMP-14 and CXCR4 were significantly overexpressed in Day 2 grafts compared with ungrafted controls, but not TGFb1. On Day 7, overexpression was observed for IL-8, TGFb1, MMP-14 and CXCR4 compared with ungrafted controls (P , 0.05), but not for VEGF. For VEGF transcripts whose overexpression was not confirmed by real-time PCR, the level of expression was highly variable.
CXCR4 immunostaining
As illustrated in Fig. 3 , CXCR4 was mainly localized in endothelial cells lining blood vessels. Staining was mostly in membranes and cytoplasm.
No staining was observed in granulosa cells or oocytes from primordial nor primary follicles. This pattern of immunolocalization was consistently encountered in fresh tissue and frozen-thawed Day 7 grafts.
Discussion
Using a murine xenotransplantation model, the current microarray study yields new information on genes and molecular mechanisms triggered after transplantation of human ovarian tissue. Seven days after intraperitoneal grafting, the most over-represented gene functions were related to tissue remodeling, cell adhesion, migration and vascularization. These processes are likely to be triggered by hypoxic stress that avascular ovarian tissue grafts are subjected to before their revascularization. We indeed identified, by EPR oximetry, severe hypoxic conditions within grafts until Day 5, followed by progressive reoxygenation during the subsequent 5 days in this model (Van Eyck et al., 2009) .
Angiogenesis
Overexpression of key mediators of angiogenesis evidenced in the current study 7 days after transplantation appears to indicate an ongoing angiogenic process. This is consistent with the timing of ovarian tissue revascularization after grafting observed in our previous studies (Van Eyck et al., 2009) . Reperfusion of ovarian tissue was shown to be initiated on Day 5 by host vessels invading the graft and to be completed by Day 10 after reanastomosis with pre-existing human vessels within the graft. This implies a tightly regulated angiogenic process. Coordinated angiogenesis involves a balance between proangiogenic factors (such as PlGF, CXCR-4 evidenced in the current study) and their receptors with anti-angiogenic and vascular stabilizing factors (such as thrombospondin and angiopoietin pathways overexpressed in grafts).
The current study points to TGFb, a mediator of the angiogenic response after ovarian tissue transplantation, as shown in previous studies (Dissen et al., 1994; Yang et al., 2008) . It also confirms the involvement of angiopoietins, known to be essential for neovessel formation and maturation (Wu et al., 2010) . Angiopoietin-2 and its receptor were shown to be up-regulated, while angiopoietin-1 was down-regulated. Their coordinated expression is essential to consolidate VEGF-mediated neovessel formation and complex vascular network formation (Asahara et al., 1998) . The current study also demonstrated up-regulation of angiogenesis mediators never before described in the context of ovarian tissue transplantation. Placental growth factor (PlGF), another member of the VEGF sub-family involved in angiogenic processes, was shown to be strongly up-regulated after grafting. PlGF, which is known to be induced by hypoxia and inflammation (Green et al., 2001) , may potentiate the mitogenic action of VEGF on endothelial cells (Park et al., 1994) .
Our microarray and PCR data also suggest strong up-regulation of the C-X-C chemokine receptor type 4 (CXCR4) after grafting. Immunohistochemical analysis showed strong expression of CXCR4 in endothelial cells lining blood vessels in ovarian tissue grafts. CXCR4 and its ligand, stromal-derived factor-1 (SDF-1), are strongly up-regulated under hypoxic conditions in monocytes, macrophages, stem cells and endothelial cells. The SDF-1/CXCR4 axis is an essential cell migration and adhesion signaling system, playing an important role in tissue restructuring (Schioppa et al., 2003) . In the current study, its vascular immunolocalization points to its involvement in neovessel formation. Activation of CXCR4 by SDF-1 was shown to induce proliferation, chemotaxis and endothelial tube formation (Heidemann et al., 2004) . In the neonatal murine ovary, the CXCR4/SDF-1 axis was also found to be involved in follicular development by inhibiting primordial to primary follicle transition (Holt et al., 2006) . However, in the current study, we did not evidence CXCR4 immunostaining in follicles in grafted or ungrafted human ovarian tissue, suggesting that CXCR4 is not implicated in human adult ovarian folliculogenesis.
IL-8 signaling was also evidenced as a prominent pathway in Day 7 grafts. Il-8 is known to be mostly expressed by macrophages, epithelial cells and endothelial cells. In the ovary, IL-8 is also expressed by granulosa and theca cells from antral follicles, modulating endothelial cell permeability during ovulation (Chang et al., 1998) . IL-8 was shown to act as a proangiogenic cytokine in the context of ovarian carcinoma (Merritt et al., 2008) . In vitro, IL-8 had a direct impact on endothelial cells by enhancing their proliferation and survival, and by inducing MMP-9 expression, also strongly overexpressed in Day 7 grafts (Li et al., 2004) . However, as a pro-inflammatory factor, IL-8 may have a negative impact after tissue transplantation by attracting neutrophils (Neri et al., 2007) . The IL-8 axis clearly merits further investigation in the context of ovarian physiology and grafting.
TGFb1, another cytokine up-regulated in ovarian xenografts, plays an important role in the control of vascular function (Goumans et al., 2009 and extracellular matrix synthesis in endothelial cells and vascular smooth muscle cells. TGFb1 also appears to play a key role in reproductive function, as null mutation in TGFb1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest in mice (Ingman and Robertson, 2009 ).
Neurogenesis
Neurogenic factors appear to be down-regulated after grafting, including neuron-specific gene family member 1, dystrophin, neurofascin and synaptotagmin I. This may be explained by a slow reinervation process after ovarian tissue grafting, in line with observations made after grafting of other tissue types, where nerves were evidenced in grafts after several months (Takahashi et al., 2001) .
Tissue remodeling
On Day 7 post-transplantation, several genes involved in extracellular matrix remodeling (MMP14, MMP9) are up-regulated and tissue development is among the most over-represented of gene functions. These results are in accordance with our histological observations, showing necrotic tissue 2 days after transplantation gradually replaced by fibrotic tissue by Day 7. Over time, the remnants of necrotic tissue are gradually resorbed and replaced by scar tissue. Stromal tissue damage may be Table SI. ascribed to both the freezing process and post-transplantation ischemic stress in the interval between tissue collection and graft revascularization (Kim et al., 2004; Van Eyck et al., 2009) .
Interestingly, extracellular proteases such as serine proteases and matrix metalloproteinases (MMPs), which were found to be strongly up-regulated after grafting, are known to play pivotal roles in physiological folliculogenesis and ovulatory processes (Rodgers et al., 2003; Smith et al., 2002) . Under physiological conditions, the ovary undergoes cyclic remodeling of its extracellular matrix to allow growth and expansion of the follicle and breakdown and repair of the follicular wall at the time of ovulation.
Fibroblast activation protein alpha, a gelatinase of the serine protease family, also appears to be induced after grafting. Although this protein was not detected in normal ovarian tissue by immunohistochemistry , it was found to be overexpressed in ovarian cancer.
Extracellular matrix remodeling essential for tissue repair and revascularization may be mediated by the peroxisome PPAR pathway. This pathway was shown to be up-regulated on Day 7 after grafting using both Ingenuity and KEGG pathway analysis tools. PPARs are a family of transcription factors involved in various processes such as steroidogenesis, angiogenesis, tissue remodeling, cell cycles, apoptosis and lipid metabolism. PPARs regulate the balance of proteolytic enzymes and their inhibitors involved in tissue remodeling and angiogenesis. However, alterations in PPAR signaling may also impact on follicular development and oocyte maturation. Transgenic mice lacking PPARg indeed showed reduced fertility (Cui et al., 2002) , although the mechanisms involved are poorly understood.
Interestingly, tumor necrosis factor-alpha-induced protein 6 (TGS-6) was shown to be present in ovarian tissue grafts. This hyaluronan-binding protein induced by prostaglandins is essential to maintain the integrity of cumulus -oocyte complexes (Ochsner et al., 2003) . Besides its role in the maintenance of extracellular matrix stability, its hyaluronan-binding domain is also known to be involved in cell migration.
Future prospects
The hypoxic conditions that human ovarian tissue is subjected to up to Day 10 after transplantation (Van Eyck et al., 2010) induce profound alterations in genes associated with extracellular matrix restructuring and vascular network formation essential for tissue survival. This results in large fibrotic tissue scarring persisting in the long term, as observed in xenografts as well as in patients , and may induce changes in the vascular network (Van Eyck et al., 2010) . As extracellular matrix proteins and angiogenic mediators involved in these processes after grafting are also implicated in folliculogenesis, this may account for the reduction in oocyte quality encountered in ovarian tissue grafts (Dolmans et al., 2009) .
It would be interesting to evaluate the consequences of ovarian tissue grafting on gene expression at the follicular level. Unfortunately, despite careful selection of biopsies containing numerous follicles, follicle markers showed low expression levels and could not be analyzed in the present study. To specifically screen the pattern of expression in follicles after grafting, enzymatic isolation (Vanacker et al., 2011) or laser capture microdissection of follicles within tissue (Markholt et al., 2012) may be considered.
Several strategies have been tested to reduce hypoxic stress after ovarian tissue transplantation, including addition of angiogenic factors to hasten revascularization (Shikanov et al., 2011; Friedman et al, 2012; Labied et al., 2013) and supplementation with antioxidant to reduce oxidative stress (Friedman et al., 2012) .
VEGF previously emerged as a promising option to precipitate recruitment of blood vessels and promote graft reperfusion in xenotransplantation models (Shikanov et 2013). Expression levels of VEGF were highly variable in the current study, which highlights the importance of other mediators of the postgrafting angiogenic response that may potentiate the effect of VEGF. PlGF, as a VEGFR1-specific agonist, may act synergically with VEGF to promote neovessel formation, as demonstrated for tumor vasculogenesis in a murine model (Li et al., 2009) . To enhance endothelial cell recruitment, combining VEGF with SDF-1 may be considered in order to attract endothelial cells expressing CXCR4. Use of VEGF and SDF-1 together rather than individually has been proposed as a strategy to improve therapeutic neovascularization (Yu et al., 2009) . Concerted actions of VEGF with additional mediators, such as angiopoietins, may be beneficial to favor vessel stabilization and maturation (Thurston, 2002) .
In conclusion, this study has contributed to identifying differences in gene expression after human ovarian tissue xenografting. Some of the genes have not been previously described in this tissue, so the present data provide a basis for future studies on their function and regulation. Increased knowledge of gene expression would enhance our understanding of molecular pathways involved in graft recovery and follicular development after grafting. This would allow appropriate action to be taken to improve the life span of the graft.
